Query author contributions in Reactome Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome .
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Binding of CBL to ligand-responsive p-6Y-EGFR mutants
Class:Id Reaction:1225949
_displayName Binding of CBL to ligand-responsive p-6Y-EGFR mutants
_doRelease TRUE
_timestamp 2018-12-19 15:20:23
authored [InstanceEdit:1972359] Orlic-Milacic, M, 2011-11-04
compartment [Compartment:876] plasma membrane [Compartment:70101] cytosol [Compartment:984] extracellular region
created [InstanceEdit:1225955] Orlic-Milacic, Marija, 2011-03-03
disease [Disease:1500689] cancer
edited [InstanceEdit:1972360] D'Eustachio, P, 2011-11-07 [InstanceEdit:1972361] Matthews, L, 2011-11-07 [InstanceEdit:1990852] Gillespie, ME, 2011-11-07 [InstanceEdit:1990853] Wu, G, 2011-11-07
entityFunctionalStatus [EntityFunctionalStatus:5637728] gain_of_function of Ligand-responsive p-6Y-EGFR mutant dimers [plasma membrane]
input [DefinedSet:1181062] Ligand-responsive p-6Y-EGFR mutant dimers [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:112199] CBL [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:112199] CBL [cytosol] [Homo sapiens]
isChimeric FALSE
literatureReference [LiteratureReference:1225829] Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways [LiteratureReference:1225925] Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized [LiteratureReference:1225923] Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors [LiteratureReference:1248637] Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII [LiteratureReference:2008120] EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes [LiteratureReference:1181018] Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants [LiteratureReference:2008166] EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer [LiteratureReference:2008165] Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain [LiteratureReference:2008136] Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition
modified [InstanceEdit:1235092] Orlic-Milacic, Marija, 2011-03-23 [InstanceEdit:1246111] Orlic-Milacic, Marija, 2011-04-01 [InstanceEdit:1247850] Orlic-Milacic, Marija, 2011-04-07 [InstanceEdit:1247851] Orlic-Milacic, Marija, 2011-04-07 [InstanceEdit:1643689] Orlic-Milacic, Marija, 2011-10-11 [InstanceEdit:1660495] Orlic-Milacic, Marija, 2011-10-13 [InstanceEdit:1979631] Orlic-Milacic, Marija, 2011-11-08 [InstanceEdit:1990842] Orlic-Milacic, Marija, 2011-11-14 [InstanceEdit:1990854] Orlic-Milacic, Marija, 2011-11-14 [InstanceEdit:1990860] Orlic-Milacic, Marija, 2011-11-14 [InstanceEdit:1998737] Orlic-Milacic, Marija, 2011-11-19 [InstanceEdit:2008180] Orlic-Milacic, Marija, 2011-11-21 [InstanceEdit:2023591] Matthews, L, 2011-12-09 [InstanceEdit:5637816] Orlic-Milacic, Marija, 2014-11-12 [InstanceEdit:5638335] Orlic-Milacic, Marija, 2014-11-13 [InstanceEdit:9632499] Orlic-Milacic, Marija, 2018-12-19 [InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
name Binding of CBL to ligand-responsive p-6Y-EGFR mutants
normalReaction
output [Complex:1225855] Ligand-responsive p-6Y-EGFR mutants:CBL [plasma membrane] [Homo sapiens]
precedingEvent
releaseDate 2011-12-06
reviewed [InstanceEdit:1990843] Greulich, H, 2011-11-15 [InstanceEdit:1990844] Savas, S, 2011-11-15
reviewStatus [ReviewStatus:9821382] five stars
species [Species:48887] Homo sapiens
stableIdentifier [StableIdentifier:2016180] R-HSA-1225949.3
summation [Summation:1225953] CBL binds to phosphorylated tyrosine Y1069 (i.e. Y1045 in th...
(hasEvent) [Pathway:1169434] Signaling by constitutively active EGFR kinase domain mutants [Homo sapiens] [Pathway:1236382] Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants [Homo sapiens]
(precedingEvent) [Reaction:1225960] Phosphorylation of CBL by ligand-responsive p-6Y-EGFR mutants [Homo sapiens]
(updatedInstance) [_UpdateTracker:9778078] Update Tracker - [Reaction:1225949] Binding of CBL to ligand-responsive p-6Y-EGFR mutants - v68:[add_removeInput] [_UpdateTracker:9835775] Update Tracker - [Reaction:1225949] Binding of CBL to ligand-responsive p-6Y-EGFR mutants - v85:[modifyText] [_UpdateTracker:9846766] Update Tracker - [Reaction:1225949] Binding of CBL to ligand-responsive p-6Y-EGFR mutants - v84:[modifyText]
[Change default viewing format]
List...
Protein identifiers
ChEBI identifiers
KEGG COMPOUND identifiers
No pathways have been reviewed or authored by Binding of CBL to ligand-responsive p-6Y-EGFR mutants (1225949)